{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:36:43Z","timestamp":1787071003194,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>We planned this study to assess endometrial cancer (EC) patients who had late metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This retrospective study constituted a review of the records of patients who were diagnosed with EC and underwent hysterectomy at the Gynecologic Oncology Clinic between 1996 and 2018. Relapses occurring after the first three years following primary treatment of EC are considered late recurrences. Post-relapse survival (PRS) refers to the time to the last follow-up or the patient\u2019s death after relapse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Late metastases were identified in 42 patients, 20 (47.6%) of whom had locoregional recurrence and 22 of whom (52.4%) had extrapelvic recurrence. Median disease-free survival (DFS) times were 61 (range: 43\u201378) and 65 (range: 48\u201381) months for the groups with locoregional and extrapelvic recurrences, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.462). The 5-year PRS rate for the patients was 61.1%, with 63.8% having locoregional and 59.4% having extrapelvic late metastasis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.969).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Among the patients with late metastases, those with endometrioid type EC were found to have a better prognosis. It has been shown that locoregional or extrapelvic organ recurrence does not significantly affect survival in patients with late relapse. Although our results are not statistically significant for cases of locoregional late metastases, surgical resection increases survival rates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_888_22","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T15:02:41Z","timestamp":1711810961000},"page":"232-237","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Characteristics of patients with late recurrence endometrial cancer"],"prefix":"10.4103","volume":"20","author":[{"given":"\u0130lker","family":"\u00c7ak\u0131r","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tepecik Education and Research Hospital, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varol","family":"G\u00fclseren","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Division of Gynecologic Oncology, Erciyes University, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130sa Aykut","family":"\u00d6zdemir","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Sadi Konuk Education and Research Hospital, \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Abac\u0131","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tepecik Education and Research Hospital, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra Canan Kelten","family":"Talu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tepecik Education and Research Hospital, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z\u00fcbeyde Emiralio\u011flu","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tepecik Education and Research Hospital, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Ata","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tepecik Education and Research Hospital, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O\u011fuzhan","family":"Kuru","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tepecik Education and Research Hospital, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"G\u00f6k\u00e7\u00fc","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tepecik Education and Research Hospital, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffer","family":"Sanc\u0131","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tepecik Education and Research Hospital, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemal","family":"G\u00fcng\u00f6rd\u00fck","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Division of Gynecologic Oncology, S\u0131tk\u0131 Ko\u00e7man University, Mu\u011fla, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,8]]},"reference":[{"key":"R1-20260507","first-page":"9","article-title":"Cancer statistics,","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"R2-20260507","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000365086","article-title":"Anovel preoperative scoring system for predicting endometrial cancer in patients with complex atypical endometrial hyperplasia and accuracy of frozen section pathological examination in this context:A multicenter study","volume":"79","author":"Gungorduk","year":"2015","journal-title":"Gynecol Obstet Invest"},{"key":"R3-20260507","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/14737140.2018.1491311","article-title":"Management strategies for recurrent endometrial cancer","volume":"18","author":"Connor","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"R4-20260507","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.7314\/APJCP.2015.16.9.3861","article-title":"Relapse patterns and outcomes following recurrence of endometrial cancer in northern Thai women","volume":"16","author":"Kaewpangchan","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"R5-20260507","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/IGC.0000000000000984","article-title":"Clinicopathological features of early and late recurrence of endometrial carcinoma after surgical resection","volume":"27","author":"Takahashi","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"R6-20260507","first-page":"879","article-title":"Costs and benefits of routine follow-up after curative treatment for endometrial cancer","volume":"157","author":"Agboola","year":"1997","journal-title":"CMAJ"},{"key":"R7-20260507","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1102\/1470-7330.2013.0011","article-title":"Typical and atypical metastatic sites of recurrent endometrial carcinoma","volume":"13","author":"Kurra","year":"2013","journal-title":"Cancer Imaging"},{"key":"R8-20260507","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejca.2016.09.033","article-title":"The nature of early-stage endometrial cancer recurrence:A national cohort study","volume":"69","author":"Jeppesen","year":"2016","journal-title":"Eur J Cancer"},{"key":"R9-20260507","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1007\/s43032-021-00565-8","article-title":"The prediction of recurrence in low-risk endometrial cancer:Is \u0131t time for a paradigm shift in adjuvant therapy?","volume":"29","author":"Laban","year":"2022","journal-title":"Reprod Sci"},{"key":"R10-20260507","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crad.2006.06.015","article-title":"Recurrent endometrial cancer:Patterns of recurrent disease and assessment of prognosis","volume":"62","author":"Sohaib","year":"2007","journal-title":"Clin Radiol"},{"key":"R11-20260507","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":"Follow-up after primary therapy for endometrial cancer:A systematic review","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R12-20260507","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00432-018-2711-8","article-title":"Endometrial cancer subtypes are associated with different patterns of recurrence","volume":"144","author":"Ignatov","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"R13-20260507","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1097\/IGC.0000000000001346","article-title":"The clinical features of recurrent endometrial cancer in Japan","volume":"28","author":"Iwase","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"R14-20260507","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2019.04.676","article-title":"Recurrent early stage endometrial cancer:Patterns of recurrence and results of salvage therapy","volume":"154","author":"Francis","year":"2019","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_888_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:14Z","timestamp":1787067614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_888_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,8]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_888_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,8]]},"assertion":[{"value":"2022-04-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}